The-risks-and-challenges-of-the-global-COVID-19-vaccine-rollout-vF.pdf?shouldIndex=f
![]()
|
Risk Practice The risks and challenges of the global COVID-19- vaccine rollout A realistic assessment of the heroic effort to administer billions of doses of COVID-19 vaccines to an agonized global population is necessary the stakes could not be higher. This article was a collaborative effort by the global Risk Practice and authors from across the firm, including Gaurav Agrawal, Tara Azimi, Jennifer Heller, Pooja Kumar, Mihir Mysore, Parag Patel, Adam Sabow, Shubham Singhal, and Joseph Truesdale |
McKinsey |
, vaccines to an agonized , vaccine , united states , vaccines , risks , doses , challenges , vaccine doses , global , critical risk areas , risk , centers for disease control , administration , states , vaccine deployment , united , critical risk , manufacturers , production , risk areas , disease |
31-Jan-2021 |
auto-generated |
